Literature DB >> 33426164

Central Cognitive Processing Speed Is an Early Marker of Huntington's Disease Onset.

Jody Corey-Bloom1,2, McKenna E Williams3, Ilex Beltran-Najera3, Andrea I Mustafa1, Chase M Snell1, Jordan Castleton1, Haileigh Smith1, Brenton Wright1, Paul E Gilbert2,3.   

Abstract

BACKGROUND: Several studies have suggested that cognitive processing speed may be useful for assessing early cognitive change in premanifest Huntington's disease (HD); however, current measures lack the ability to control for the effects of motor dysfunction commonly found in HD. The Computerized Test of Information Processing (CTiP) is a rapidly administered computerized tool that allows for the examination of central cognitive processing speed by using motor-corrected scores to account for motor dysfunction.
OBJECTIVE: To examine central cognitive processing speed as an early marker of HD onset using the CTiP.
METHODS: The CTiP and other measures were administered to 102 HD gene carriers and 55 healthy adults (HA). Gene carriers included presymptomatic HD (pre-HD; n = 33), prodromal HD (pro-HD; ie, individuals close to disease onset; n = 23), and mild-moderate HD (HD; n = 46).
RESULTS: The HD group performed significantly slower than all other groups (HA, pre-HD, and pro-HD) on most subtests (Ps < .05). Moreover, the pro-HD group performed significantly slower than the HA group on both motor-corrected subtests (Ps < 0.05). Effect sizes associated with significant group differences between the pro-HD and HA groups on motor-corrected CTiP subtests (d = 0.73 and 0.84) were similar to effect sizes associated with group differences on the Symbol Digit Modalities Test (d = .82) and other traditional cognitive assessments (Montreal Cognitive Assessment, d = .75; Mini-Mental State Examination, d = .84).
CONCLUSIONS: The CTiP may be a useful marker of deficits in central cognitive processing speed in individuals close to manifest onset of HD.
© 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Huntington's disease; cognition; computerized test of information processing; premanifest Huntington's disease; processing speed

Year:  2020        PMID: 33426164      PMCID: PMC7781078          DOI: 10.1002/mdc3.13121

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  15 in total

1.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Authors:  Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2011-12-02       Impact factor: 44.182

2.  The effects of mild and severe traumatic brain injury on speed of information processing as measured by the computerized tests of information processing (CTIP).

Authors:  Tom N Tombaugh; Laura Rees; Peter Stormer; Allyson G Harrison; Andra Smith
Journal:  Arch Clin Neuropsychol       Date:  2006-10-27       Impact factor: 2.813

3.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

4.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

5.  Identification of Subtle Verbal Memory Deficits in Premanifest Huntington Disease Using the California Verbal Learning Test.

Authors:  Heather M Holden; Savanna M Tierney; Lisa V Graves; Ilex Beltran-Najera; Steven Paul Woods; Chase M Snell; Dean C Delis; Jody Corey-Bloom; Paul E Gilbert
Journal:  Cogn Behav Neurol       Date:  2020-03       Impact factor: 1.600

6.  The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease.

Authors:  Eva Pirogovsky; Diane R Nicoll; Dillon M Challener; Elizabeth Breen; Shea Gluhm; Jody Corey-Bloom; Paul E Gilbert
Journal:  J Neuropsychol       Date:  2013-12-11       Impact factor: 2.864

7.  Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.

Authors:  Ida Unmack Larsen; Tua Vinther-Jensen; Anders Gade; Jørgen Erik Nielsen; Asmus Vogel
Journal:  J Int Neuropsychol Soc       Date:  2015-04-08       Impact factor: 2.892

8.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

9.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

10.  Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.

Authors:  Christopher A Ross; Ralf Reilmann; Francisco Cardoso; Elizabeth A McCusker; Claudia M Testa; Julie C Stout; Blair R Leavitt; Zhong Pei; Bernhard Landwehrmeyer; Asuncion Martinez; Jamie Levey; Teresa Srajer; Jee Bang; Sarah J Tabrizi
Journal:  Mov Disord Clin Pract       Date:  2019-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.